Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-05-11 Sale | 2021-05-13 7:49 pm | ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK Yalamanchi Naveen Director 10% Owner | 725,000 | $40.03 | $29,023,490 | 16,460,119 (Indirect) | View |
| 2020-12-10 Purchase | 2020-12-14 7:19 pm | ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK Yalamanchi Naveen Director 10% Owner | 247,720 | $56 | $13,872,320 | 17,530,044 (Indirect) | View |
| 2019-12-10 Purchase | 2019-12-12 3:43 pm | ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK Yalamanchi Naveen Director 10% Owner | 225,000 | $22.25 | $5,006,250 | 17,282,324 (Indirect) | View |
| 2019-04-16 Purchase | 2019-04-18 4:14 pm | ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK Yalamanchi Naveen Director 10% Owner | 550,005 | $17.5 | $9,625,088 | 17,057,324 (Indirect) | View |
| 2018-08-01 Sale | 2018-08-03 7:03 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Yalamanchi Naveen Director | 637 | $22 | $14,014 | 113,641 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-13 Option Award | 2022-06-15 9:07 pm | N/A 2032-06-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Yalamanchi Naveen Director | 47,745 | $0 | 47,745 (Direct) | View |
| 2021-08-27 Option Award | 2021-08-31 7:11 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | WONG RODERICK RTW INVESTMENTS LP Yalamanchi Naveen Director 10% Owner | 812,516 | $32.48 | 16,272,635 (Indirect) | View |
| 2021-06-14 Option Award | 2021-06-16 7:50 pm | N/A 2031-06-14 | ROCKET PHARMACEUTICALS INC. | RCKT | Yalamanchi Naveen Director | 12,236 | $0 | 12,236 (Direct) | View |
| 2021-05-11 Other | 2021-05-13 7:49 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK Yalamanchi Naveen Director 10% Owner | 1 | $0 | 16,460,119 (Indirect) | View |
| 2021-03-24 Other | 2021-03-29 8:01 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK Yalamanchi Naveen Director 10% Owner | 1,344,925 | $0 | 17,530,044 (Indirect) | View |
| 2020-12-02 Ownership | 2021-02-16 9:54 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Yalamanchi Naveen Director | 31,250 | $0 | 82,391 (Indirect) | View |
| 2020-06-16 Option Award | 2020-06-18 9:38 pm | N/A 2030-06-16 | ROCKET PHARMACEUTICALS INC. | RCKT | Yalamanchi Naveen Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2019-01-28 Option Award | 2019-01-30 6:33 pm | N/A 2029-01-28 | ROCKET PHARMACEUTICALS INC. | RCKT | Yalamanchi Naveen Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2018-12-28 Option Award | 2018-12-28 5:43 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | WONG RODERICK RTW INVESTMENTS LP Yalamanchi Naveen Director 10% Owner | 100,000 | $13.93 | 16,507,319 (Indirect) | View |
| 2018-11-27 Option Award | 2018-11-29 6:02 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | WONG RODERICK RTW INVESTMENTS LP Yalamanchi Naveen Director 10% Owner | 967,742 | $15.5 | 16,407,319 (Indirect) | View |
| 2018-08-27 Other | 2018-08-29 6:48 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK Yalamanchi Naveen 10% Owner | 2 | $0 | 2 (Indirect) | View |
| 2018-03-29 Option Award | 2018-04-02 8:17 pm | N/A 2028-03-29 | ROCKET PHARMACEUTICALS INC. | RCKT | Yalamanchi Naveen Director | 40,000 | $0 | 40,000 (Direct) | View |